However, in tumor cells, the disrupted interaction between p53 and Hsp90 could inhibit p53 degradation, leading to the accumulation and aggregation of p53 proteins, ultimately resulting in the loss of their tumor suppressive function [47, 48]. This evidence concerns the gene TP53 and neoplasm.